Date published: 2026-3-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

Lck Inhibitors

Lck inhibitors constitute a specialized class of compounds meticulously designed to selectively target and impede the activity of lymphocyte-specific protein tyrosine kinase (Lck), an enzyme pivotal in orchestrating the initiation of T-cell receptor (TCR) signaling. Lck's role is instrumental as it catalyzes the phosphorylation of diverse components within the TCR complex, thereby instigating a cascade of events leading to the activation of downstream signaling pathways crucial for T-cell activation and the elicitation of immune responses. The mechanistic essence of Lck inhibitors lies in their precision in homing in on the Lck enzymean architect of T-cell signaling dynamics. These inhibitors, purposefully crafted, exhibit the ability to intricately interfere with Lck's enzymatic activity, specifically hindering its capacity to phosphorylate signaling molecules associated with the TCR complex. This strategic interference holds the promise of modulating the initiation phase of T-cell signaling, thereby exerting influence over subsequent immune responses.Ongoing scientific inquiry into Lck inhibitors is characterized by a meticulous quest to unveil the precise modalities through which these compounds exert their effects. The focus is on unraveling the intricacies of Lck's kinase activity and its intricate role in governing T-cell signaling within the complex landscape of immune regulation. The study of Lck inhibitors, therefore, emerges as a scientific frontier, offering insights into the molecular nuances that govern immune responses and cellular communication. The intricate dance orchestrated by Lck in initiating T-cell signaling, coupled with its implications for immune regulation, positions Lck inhibitors as invaluable tools for dissecting the complex interplay between signaling dynamics and immune responses. As research advances, the knowledge garnered from Lck inhibitors enriches our understanding of the intricate mechanisms underlying immune regulation, contributing to the broader landscape of immunology and cellular communication.

SEE ALSO...

Items 11 to 14 of 14 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

CGP 57380

522629-08-9sc-202993
5 mg
$172.00
6
(1)

CGP 57380 acts by binding to the ATP-binding site within the kinase domain of Lck. This binding interferes with the kinase's ability to transfer phosphate groups from ATP to target proteins, which is a critical step in its enzymatic activity.

Lck Inhibitor III

1188890-30-3sc-311372
5 mg
$660.00
(0)

Lck Inhibitor III functions as a selective inhibitor of the Lck enzyme, exhibiting unique binding dynamics through hydrophobic interactions and van der Waals forces with critical residues in the active site. This compound stabilizes an inactive conformation of Lck, preventing substrate access. Its kinetic profile reveals a rapid initial binding phase followed by a slower dissociation, ensuring prolonged inhibition. Additionally, the compound's structural characteristics facilitate enhanced specificity for Lck, minimizing off-target effects.

Anomalin A

548740-86-9sc-364099
1 mg
$133.00
(0)

Anomalin A acts as a potent Lck inhibitor, characterized by its ability to disrupt the enzyme's phosphorylation activity. It engages in specific hydrogen bonding and electrostatic interactions with key amino acid residues, effectively altering the enzyme's conformation. The compound exhibits a unique allosteric modulation, influencing the enzyme's catalytic efficiency. Its reaction kinetics demonstrate a biphasic binding pattern, allowing for sustained inhibition while maintaining selectivity against similar kinases.

A 419259 trihydrochloride

1435934-25-0sc-361094
5 mg
$213.00
6
(1)

A 419259 trihydrochloride acts as a potent Lck inhibitor, characterized by its ability to disrupt the enzyme's active site through specific electrostatic interactions. This compound exhibits a unique binding affinity, stabilizing an inactive conformation of Lck. Its kinetic profile reveals a fast initial binding phase, followed by a gradual transition to a stable complex, effectively altering downstream signaling cascades. The compound's solubility properties further enhance its interaction dynamics within cellular environments.